| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management G Raghu, HR Collard, JJ Egan, FJ Martinez, J Behr, KK Brown, TV Colby, ... American journal of respiratory and critical care medicine 183 (6), 788-824, 2011 | 8560* | 2011 |
| Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ... New England Journal of Medicine 370 (22), 2071-2082, 2014 | 4029 | 2014 |
| An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias WD Travis, U Costabel, DM Hansell, TE King Jr, DA Lynch, AG Nicholson, ... American journal of respiratory and critical care medicine 188 (6), 733-748, 2013 | 3498 | 2013 |
| Idiopathic pulmonary fibrosis TE King, A Pardo, M Selman The Lancet 378 (9807), 1949-1961, 2011 | 3139* | 2011 |
| Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer, ... American journal of respiratory and critical care medicine 198 (5), e44-e68, 2018 | 2747 | 2018 |
| Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy M Selman, TE King Jr, A Pardo Annals of internal medicine 134 (2), 136-151, 2001 | 2154 | 2001 |
| Acute exacerbations of idiopathic pulmonary fibrosis HR Collard, BB Moore, KR Flaherty, KK Brown, RJ Kaner, TE King Jr, ... American journal of respiratory and critical care medicine 176 (7), 636-643, 2007 | 1288 | 2007 |
| Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis L Richeldi, U Costabel, M Selman, DS Kim, DM Hansell, AG Nicholson, ... New England Journal of Medicine 365 (12), 1079-1087, 2011 | 1237 | 2011 |
| An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease KC Meyer, G Raghu, RP Baughman, KK Brown, U Costabel, RM Du Bois, ... American journal of respiratory and critical care medicine 185 (9), 1004-1014, 2012 | 997 | 2012 |
| American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias WD Travis, TE King, ED Bateman, DA Lynch, F Capron, D Center, ... American journal of respiratory and critical care medicine 165 (2), 277-304, 2002 | 946 | 2002 |
| Idiopathic pulmonary fibrosis FJ Martinez, HR Collard, A Pardo, G Raghu, L Richeldi, M Selman, ... Nature reviews Disease primers 3 (1), 1-19, 2017 | 847 | 2017 |
| The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak AM Tager, P LaCamera, BS Shea, GS Campanella, M Selman, Z Zhao, ... Nature medicine 14 (1), 45-54, 2008 | 822 | 2008 |
| Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis TE Fingerlin, E Murphy, W Zhang, AL Peljto, KK Brown, MP Steele, ... Nature genetics 45 (6), 613-620, 2013 | 747 | 2013 |
| Clinical diagnosis of hypersensitivity pneumonitis Y Lacasse, M Selman, U Costabel, JC Dalphin, M Ando, F Morell, ... American journal of respiratory and critical care medicine 168 (8), 952-958, 2003 | 744 | 2003 |
| Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans F Zuo, N Kaminski, E Eugui, J Allard, Z Yakhini, A Ben-Dor, L Lollini, ... Proceedings of the National Academy of Sciences 99 (9), 6292-6297, 2002 | 719 | 2002 |
| Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD L Segura-Valdez, A Pardo, M Gaxiola, BD Uhal, C Becerril, M Selman Chest 117 (3), 684-694, 2000 | 683 | 2000 |
| Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project WD Travis, G Hunninghake, TE King Jr, DA Lynch, TV Colby, JR Galvin, ... American journal of respiratory and critical care medicine 177 (12), 1338-1347, 2008 | 654 | 2008 |
| TIMP-1,-2,-3, and-4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? M Selman, V Ruiz, S Cabrera, L Segura, R Ramirez, R Barrios, A Pardo American Journal of Physiology-Lung Cellular and Molecular Physiology 279 (3 …, 2000 | 588 | 2000 |
| MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis IO Rosas, TJ Richards, K Konishi, Y Zhang, K Gibson, AE Lokshin, ... PLoS medicine 5 (4), e93, 2008 | 587 | 2008 |
| Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers M Selman, A Pardo Proceedings of the American Thoracic Society 3 (4), 364-372, 2006 | 575 | 2006 |
